Denver, Colorado, February 18th, 2026, Chainwire

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical and med-tech company advancing cancer treatments, announced the appointment of Sidney Braun as Chief Executive Officer of its Liora Technologies Europe Ltd. subsidiary. Braun, who previously facilitated LIXTE’s November 2025 acquisition of Liora’s assets, brings more than 20 years of healthcare operational and strategic advisory experience and […]

Datavault AI (NASDAQ: DVLT) updated its preliminary, unaudited fiscal 2025 revenue estimate to $38 million to $40 million, exceeding its prior $30 million estimate by up to 33%, with midpoint growth of approximately 1,300% year over year, driven by customer tech-licensing fees and tokenization and monetization services from its Data Science Group. The company also reaffirmed […]

From biotech scale-ups to AI infrastructure partnerships and balance sheet resets, today’s headlines center on stocks moving from concept to commercialization.